ICS can interact with other medications, potentially altering their efficacy or increasing the risk of side effects. For example, the concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) can increase plasma concentrations of certain ICS, elevating the risk of systemic side effects.
